- 1.
Tahir MN, Shahbazi F, Rondeau-Gagné S et al. The biosynthesis of the cannabinoids. J Cannabis Res 2021; 3: 7. [PubMed][CrossRef]
- 2.
Wiley JL, Marusich JA, Huffman JW et al. Hijacking of Basic Research: The Case of Synthetic Cannabinoids. Methods Rep RTI Press 2011; 2011: 17971. [PubMed][CrossRef]
- 3.
EUDA. EU Drug Market: New psychoactive substances — Distribution and supply in Europe: Semi-synthetic cannabinoids. https://www.euda.europa.eu/publications/eu-drug-markets/new-psychoactive-substances/distribution-and-supply/synthetic-cannabinoids_en Lest 14.1.2025.
- 4.
Darke S, Duflou J, Farrell M et al. Characteristics and circumstances of synthetic cannabinoid-related death. Clin Toxicol (Phila) 2020; 58: 368–74. [PubMed][CrossRef]
- 5.
Graziano S, Varì MR, Pichini S et al. Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance. Curr Neuropharmacol 2023; 21: 2424–30. [PubMed][CrossRef]
- 6.
Ujváry I, Evans-Brown M, Gallegos A et al. Technical Report: Hexahydrocannabinol (HHC) and related substances. https://op.europa.eu/en/publication-detail/-/publication/d379c68f-f6e9-11ee-a251-01aa75ed71a1 Lest 14.1.2025.
- 7.
Abdel-Kader MS, Radwan MM, Metwaly AM et al. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol. Molecules 2024; 29: 1249. [PubMed][CrossRef]
- 8.
Götz MR, Collado JA, Fernández-Ruiz J et al. Structure-Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives. Front Pharmacol 2019; 10: 1284. [PubMed][CrossRef]
- 9.
Bretteville-Jensen AL, Burdzovic Andreas J, Dahl SL et al. En studie om cannabiserfaringer, kunnskap og holdninger blant elever på videregående skoler. Folkehelseintstituttet, 2022. https://www.fhi.no/publ/2022/cann2021-en-studie-om-cannabiserfaringer-kunnskap-og-holdninger-blant-eleve/ Lest 14.1.2025.
- 10.
KRIPOS. Narkotika- og dopingstatistikk 1. halvår 2023. https://www.politiet.no/globalassets/tall-og-fakta/narkotika/narkotikastatistikk_2023_halvar.pdf Lest 14.1.2025.
- 11.
KRIPOS. Narkotika- og dopingstatistikk 1. halvår 2024. https://www.politiet.no/globalassets/tall-og-fakta/narkotika/narkotikastatistikk-1.-halvar-2024.pdf Lest 14.1.2025.
- 12.
Rossheim ME, LoParco CR, Tillett KK et al. Intoxicating Cannabis Products in Vape Shops: United States, 2023. Am J Prev Med 2024; 67: 776–84. [PubMed][CrossRef]
- 13.
Schirmer W, Auwärter V, Kaudewitz J et al. Identification of human hexahydrocannabinol metabolites in urine. Eur J Mass Spectrom (Chichester) 2023; 29: 326–37. [PubMed][CrossRef]
- 14.
La Maida N, Di Giorgi A, Pichini S et al. Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis. J Pharm Biomed Anal 2022; 220: 114987. [PubMed][CrossRef]
- 15.
Ferretti ML, Gournay LR, Bingaman MG et al. A Survey Study of Individuals Using Hexahydrocannabinol Cannabis Products: Use Patterns and Perceived Effects. Cannabis Cannabinoid Res 2024; 9: e1385–94. [PubMed][CrossRef]
- 16.
Food and Drug Administration. 5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC 2022. https://www.fda.gov/consumers/consumer-updates/5-things-know-about-delta-8-tetrahydrocannabinol-delta-8-thc Lest 29.12.2024.
- 17.
Reiter NN, Linnet KK, Andersen K et al. Svær forgiftning med semisyntetiske cannabinoider. Ugeskr Laeger 2024; 186: V04240241. [PubMed][CrossRef]
- 18.
Tweet MS, Nemanich A, Wahl M. Pediatric Edible Cannabis Exposures and Acute Toxicity: 2017-2021. Pediatrics 2023; 151: e2022057761. [PubMed][CrossRef]
- 19.
Schmid Y, Scholz I, Mueller L et al. Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland. Drug Alcohol Depend 2020; 206: 107726. [PubMed][CrossRef]
()